2022
Sex-specific impact of diabetes on all-cause mortality among adults with acute myocardial infarction: An updated systematic review and meta-analysis, 1988-2021
Ding Q, Funk M, Spatz ES, Lin H, Batten J, Wu E, Whittemore R. Sex-specific impact of diabetes on all-cause mortality among adults with acute myocardial infarction: An updated systematic review and meta-analysis, 1988-2021. Frontiers In Endocrinology 2022, 13: 918095. PMID: 36060979, PMCID: PMC9428712, DOI: 10.3389/fendo.2022.918095.Peer-Reviewed Original ResearchConceptsAcute myocardial infarctionCause mortalityRisk ratioDiabetes statusMyocardial infarctionSystematic reviewRandom-effects meta-analysis modelEffects meta-analysis modelPatients' diabetes statusLong-term mortalityPrevalence of diabetesCause mortality riskImpact of diabetesSex-specific analysesMeta-analysis modelSex-specific impactAMI survivorsUnadjusted analysesEligible studiesAMI treatmentInclusion criteriaMortality riskHigh riskDiabetesSustained effect
2021
Systematic Review and Meta-analysis: An Empirical Approach to Defining Treatment Response and Remission in Pediatric Obsessive-Compulsive Disorder
Farhat LC, Vattimo EFQ, Ramakrishnan D, Levine JLS, Johnson JA, Artukoglu BB, Landeros-Weisenberger A, Asbahr FR, Cepeda SL, Comer JS, Fatori D, Franklin ME, Freeman JB, Geller DA, Grant PJ, Goodman WK, Heyman I, Ivarsson T, Lenhard F, Lewin AB, Li F, Merlo LJ, Mohsenabadi H, Peris TS, Piacentini J, Rosa-Alcázar AI, Rosa-Alcázar À, Rozenman M, Sapyta JJ, Serlachius E, Shabani MJ, Shavitt RG, Small BJ, Skarphedinsson G, Swedo SE, Thomsen PH, Turner C, Weidle B, Miguel EC, Storch EA, Mataix-Cols D, Bloch MH. Systematic Review and Meta-analysis: An Empirical Approach to Defining Treatment Response and Remission in Pediatric Obsessive-Compulsive Disorder. Journal Of The American Academy Of Child & Adolescent Psychiatry 2021, 61: 495-507. PMID: 34597773, DOI: 10.1016/j.jaac.2021.05.027.Peer-Reviewed Original ResearchConceptsChildren's Yale-Brown Obsessive-Compulsive ScalePediatric obsessive-compulsive disorderObsessive-compulsive disorderYale-Brown Obsessive-Compulsive ScaleClinical Global Impression ImprovementObsessive-Compulsive ScaleBaseline to posttreatmentRandomized controlled clinical trialArea under the curveOptimal cutoffRaw scoresMeta-analysisClinical trialsStandard operational definitionSystematic reviewDiscrimination abilityTest accuracy meta-analysisLack of universal definitionsSystematic review of PubMedSeverity ScaleTreatment responseDiagnostic test accuracy meta-analysisControlled clinical trialsRandom-effects meta-analysis modelReview of PubMed
2017
NEUROIMAGING OF SUBCORTICAL BRAIN VOLUME ALTERATIONS IN PEADIATRIC AND ADULT OBSESSIVE-COMPULSIVE DISORDER: Preliminary findings from the ENIGMA Obsessive-Compulsive Disorder working group
Boedhoe P, Schmaal L, Reddy J, Kwon J, Cheng Y, Nakamae T, Spalletta G, Beucke J, Soriano-Mas C, Lazaro L, Fitzgerald K, Koch K, Hoexter M, Benedetti F, Nakao T, Wang Z, Mataix-Cols D, Simpson H, Walitza S, Tolin D, Arnold P, Huyser C, Denys D, Soreni N, Guner P, Group* E, Thompson P, Hibar D, Jahanshad N, Stein D, van den Heuvel O. NEUROIMAGING OF SUBCORTICAL BRAIN VOLUME ALTERATIONS IN PEADIATRIC AND ADULT OBSESSIVE-COMPULSIVE DISORDER: Preliminary findings from the ENIGMA Obsessive-Compulsive Disorder working group. European Neuropsychopharmacology 2017, 27: 617-619. DOI: 10.1016/j.euroneuro.2016.07.024.Peer-Reviewed Original ResearchBrain volume alterationsPediatric OCD patientsIndividual participant dataThalamus volumeIntracranial volumeOCD patientsDisease durationHippocampal abnormalitiesLateral ventricleSymptom severityVolume alterationsRandom-effects meta-analysis modelRobust imaging markerSeparate stratified analysesLonger disease durationAdult obsessive-compulsive disorderSmaller hippocampal volumesPathophysiology of OCDTotal intracranial volumeAdult OCD patientsMeta-regression analysisMeta-analysis modelPediatric OCD casesSubcortical brain volumesLimited statistical power
2011
Nonsteroidal Anti-inflammatory Drug Use Reduces Risk of Adenocarcinomas of the Esophagus and Esophagogastric Junction in a Pooled Analysis
Liao LM, Vaughan TL, Corley DA, Cook MB, Casson AG, Kamangar F, Abnet CC, Risch HA, Giffen C, Freedman ND, Chow W, Sadeghi S, Pandeya N, Whiteman DC, Murray LJ, Bernstein L, Gammon MD, Wu AH. Nonsteroidal Anti-inflammatory Drug Use Reduces Risk of Adenocarcinomas of the Esophagus and Esophagogastric Junction in a Pooled Analysis. Gastroenterology 2011, 142: 442-452.e5. PMID: 22108196, PMCID: PMC3488768, DOI: 10.1053/j.gastro.2011.11.019.Peer-Reviewed Original ResearchMeSH KeywordsAdenocarcinomaAdolescentAdultAgedAged, 80 and overAnti-Inflammatory Agents, Non-SteroidalAnticarcinogenic AgentsAustraliaCanadaCase-Control StudiesCohort StudiesEsophageal NeoplasmsEsophagogastric JunctionFemaleHumansLogistic ModelsMaleMiddle AgedOdds RatioRisk AssessmentRisk FactorsStomach NeoplasmsTime FactorsUnited StatesYoung AdultConceptsNonsteroidal anti-inflammatory drugsEsophagogastric junctional adenocarcinomaRisk of EACNSAID useEsophageal adenocarcinomaPooled analysisOdds ratioEsophagogastric junctionNonaspirin nonsteroidal anti-inflammatory drugsStudy-specific odds ratiosRandom-effects meta-analysis modelEffects meta-analysis modelPrevention of adenocarcinomaUse of aspirinSignificant reduced riskPopulation-based studyConfidence intervalsAnti-inflammatory drugsDuration of useEsophageal Adenocarcinoma ConsortiumMeta-analysis modelLogistic regression modelsJunctional adenocarcinomaMedication typeEAC risk
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply